Stereotaxis to Report Second Quarter 2016 Financial Results on August 9, 2016
August 02 2016 - 9:00AM
Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative
technologies for the treatment of cardiac arrhythmias, today
announced that it will release financial results for its 2016
second quarter ended June 30, 2016 on Tuesday, August 9, 2016 after
the close of the U.S. financial markets. The Company will host a
conference call and webcast at 4:30 p.m. Eastern Time that day to
discuss the Company’s results and corporate developments.
|
|
|
|
|
What: |
Stereotaxis second quarter 2016 financial results conference
call |
|
|
|
|
When: |
Tuesday, August 9th at 4:30 p.m. Eastern Time (1:30 p.m. PT) |
|
|
|
|
Dial In Number: |
To access the live call, dial
800-381-2652 (US and Canada) or
719-457-2619 (International) and give the
participant pass code 8079214. |
|
|
|
|
Webcast: |
To access the live and replay webcast, please visit the
investor relations section of Stereotaxis’ website at
www.stereotaxis.com |
|
|
|
|
Call Replay: |
A phone replay of the call will be available for one
week beginning approximately two hours following the end of the
call through Tuesday, August 16, 2016. To access the replay dial-in
information, please click here. |
|
|
|
About Stereotaxis
Stereotaxis is a healthcare technology and innovation leader in
the development of robotic cardiology instrument navigation systems
designed to enhance the treatment of arrhythmias and coronary
disease, as well as information management solutions for the
interventional lab. Over 100 issued patents support the Stereotaxis
platform, which helps physicians around the world provide
unsurpassed patient care with robotic precision and safety,
improved lab efficiency and productivity, and enhanced integration
of procedural information. Stereotaxis' core Epoch® Solution
includes the Niobe® ES remote magnetic navigation system, the
Odyssey® portfolio of lab optimization, networking and patient
information management systems, and the Vdrive® robotic navigation
system and consumables.
The core components of Stereotaxis’ systems have received
regulatory clearance in the United States, European Union, Canada,
China, Japan, and elsewhere. The V-Sono™ ICE catheter manipulator,
V-Loop™ variable loop catheter manipulator, and V-CAS™ catheter
advancement system have received clearance in the United States,
Canada, and the European Union. The V-CAS Deflect™ catheter
advancement system is available for use in the European Union. For
more information, please visit www.stereotaxis.com.
Press Contact:
Martin Stammer
Chief Financial Officer
314-678-6155
Investor Contact:
Todd Kehrli / Jim Byers
MKR Group, Inc.
323-468-2300
stxs@mkr-group.com